|
[1] SEEGER C,MASON WS.Hepatitis B virus biology[J].Microbiol Mol Biol Rev,2000,64(1):51-68.
|
|
[2]ZHOU B,LIU M,LV G,et al.Quantification of hepatitis B surface antigen and E antigen:correlation between Elecsys and Architect assays[J].J Viral Hepat,2013,20(6):422-429.
|
|
[3]CHAN HL,WONG VW,WONG GL,et al.Alongitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B[J].Hepatology,2010,52(4):1232-1241.
|
|
[4]JAROSZEWICZ J,CALLE SK,WURSTHORN K,et al.Hepatitis B surface antigen(HBs Ag)levels in the natural history of hepatitis Bvirus(HBV)-infection:a European perspective[J].J Hepatol,2010,52(4):514-522.
|
|
[5]NGUYEN T,THOMPSON AJ,BOWDEN S,et al.Hepatitis B surface antigen levels during the natural history of chronic hepatitis B:a perspective on Asia[J].J Hepatol,2010,52(4):508-513.
|
|
[6]ZHOU HB,LI JY,ZHAO YH,et al.Quantitation of hepatitis Bsurface antigen(HBs Ag)in the natural course of hepatitis B virus(HBV)-infection[J].J Harbin Med Univ,2013,47(4):350-352.(in Chinese)周洪波,李晶媛,赵勇华,等.乙型肝炎病毒感染不同阶段HBs Ag定量变化的研究[J].哈尔滨医科大学学报,2013,47(4):350-352.
|
|
[7] YUEN MF,WONG DK,SABLON E,et al.HBs Ag seroclearance in chronic hepatitis B in the Chinese:virological,histological,and clinical aspects[J].Hepatology,2004,39(6):1694-1701.
|
|
[8]RIJCKBORST V,HANSEN BE,CAKALOGLU Y,et al.Early ontreatment prediction of response to peginterferon alfa-2a for HBe Ag-negative chronic hepatitis B using HBs Ag and HBV DNA levels[J].Hepatology,2010,52(2):454-461.
|
|
[9]BRUNETTO MR,MORICONI F,BONINO F,et al.Hepatitis Bvirus surface antigen levels:a guide to sustained response to peginterferon alfa-2a in HBe Ag-negative chronic hepatitis B[J].Hepatology,2009,49(4):1141-1150.
|
|
[10]BRUNETTO MR,OLIVERI F,COLOMBATTO P,et al.Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers[J].Gastroenterology,2010,139(2):483-490.
|
|
[11]MARTINOT-PEIGNOUX M,CARVALHO-FILHO R,LAPA-LUS M,et al.Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-nave,e antigen-positive patients[J].J Hepatol,2013,58(6):1089-1095.
|
|
[12] JAROSZEWICZ J,CALLE SERRANO B,WURSTHORN K,et al.Hepatitis B surface antigen(HBs Ag)levels in the natural history of hepatitis B virus(HBV)-infection:a European perspective[J].JHepatol,2010,52(4):514-522.
|
|
[13]European Association for the Study of the Liver.EASL clinical practice guidelines:managementof chronic hepatitis B virus infection[J].J Hepatol,2012,57(1):167-185.
|
|
[14] HAN XY,CHEN XJ,YAN ZQ,et al.Correlation among HBs Ag and HBV DNA levels with liver fibrosis in patients with hepatitis B[J].Int J Virol,2016,23(1):50-56.(in Chinese)韩晓颖,陈秀记,闫泽强,等.血清HBs Ag与HBV DNA水平与乙肝患者肝纤维化程度的相关性分析[J].国际病毒学杂志,2016,23(1):50-56.
|
|
[15]PEI YZ,HAN T,MA XY,et al.The discrepancy of HBs Ag titre and HBV DNA in patients with chronic hepatitis B,HBV-related liver cirrhosis and hepatocellular carcinoma[J].Chin J Hepatol,2011,19(10):743-746.(in Chinese).裴彦祯,韩涛,马晓艳,等.HBs Ag及HBV DNA定量水平在慢性乙型肝炎、肝硬化和肝癌患者中的变化[J].中华肝脏病杂志,2011,19(10):743-746.
|
DownLoad: